Canada Ultrasound Devices Market Trends and Insights
Government Funding for Diagnostic Imaging Equipment Expansion in Canada
Federal and provincial spending programs are scaling diagnostic capacity by absorbing capital costs for ultrasound consoles and probes. Ottawa’s CAD 200 (USD 145.9) billion ten-year accord, which targets care backlogs, ring-fences allocations for imaging suites and mobile outreach units. British Columbia has already installed 18 MRI and nine CT scanners since 2024, freeing budgets for complementary ultrasound upgrades that streamline patient triage. Research infrastructure grants worth CAD 86 (USD 62.7) million awarded to 47 institutions in 2024 further bolster faculty-led ultrasound innovation pipelines. Collectively, these disbursements reduce acquisition barriers for community clinics and catalyze volume growth across the Canada ultrasound devices market.Rising Cardiovascular Disease Burden Increasing Echocardiography Volumes
Cardiovascular disease remains the country’s second-largest mortality driver after cancer, steering clinicians toward scalable non-invasive imaging modalities. AI-optimized echocardiography now supports earlier detection of left-ventricular dysfunction and cardiomyopathy at the bedside. The University of British Columbia’s publicly funded handheld-ultrasound network has equipped rural practitioners with probe-to-cloud devices that transmit real-time cardiac loops for central review, lifting diagnostic throughput while cutting patient travel. Sustained incidence trends translate into predictable capital replacement cycles, reinforcing the Canada ultrasound devices market’s mid-single-digit CAGR.Lack of Skilled Labor to Handle the Advanced Equipment
Early retirements among sonographers, averaging 60.8 years, are constricting workforce supply relative to scan demand. Manitoba’s primary training program filled only 80% of seats in 2024, signaling pipeline strain. Shortages extend to anesthesiologists and medical radiation technologists, leading to surgical postponements and under-utilization of newly procured consoles. Vendors are responding with AI-driven automation and scan-quality feedback, yet human capital remains a gating factor that trims the Canada ultrasound devices market’s effective growth rate.Other drivers and restraints analyzed in the detailed report include:
- Aging Demographics and Growth in Prenatal Screening Programs
- AI-Enabled Image Analysis Adoption Supported by Provincial Reimbursements
- Health Canada Licensing Delays for Handheld Ultrasound Devices
Segment Analysis
Radiology contributed 27.32% of the Canada ultrasound devices market size in 2025 as comprehensive abdominal, pelvic, and thyroid studies remain cornerstones of diagnostic workflows. Stable reimbursement and modality familiarity ensure radiology sustains a high baseline of console utilization in tertiary centers. Anesthesiology, however, is poised for an 8.19% CAGR to 2031, propelled by expanded peripheral nerve-block protocols and critical-care adoption of cardiac output monitoring. The anesthesiology sub-segment captured 8.27% of the Canada ultrasound devices market share last year, yet its rapid growth, aided by improved catheter visualization through high-frequency probes, underscores shifting procedural paradigms toward ultrasound-guided techniques.Cardiology follows closely, fortified by AI-assisted strain imaging that detects sub-clinical heart failure. Gynecology and obstetrics leverage 3D/4D renderings to enhance fetal anomaly detection, while emergency medicine relies on focused assessment with sonography for trauma to expedite triage. Each discipline’s evolving workflow requirements stimulate iterative hardware and software refresh cycles, sustaining value within the Canada ultrasound devices market.
Three-dimensional and four-dimensional imaging accounted for 47.88% of 2025 revenue, anchored by obstetric visualization and congenital heart defect screening. Vendors bundle volumetric rendering with cloud-share features that allow expectant parents and referring physicians to access scans remotely, strengthening patient engagement.
High-intensity focused ultrasound (HIFU) represents the innovation frontier, projected to log a 12.14% CAGR as non-invasive fibroid ablation and oncology indications secure regulatory clearances. MRI-guided HIFU systems at Sunnybrook Health Sciences Centre demonstrate fibroid volume reductions of up to 50%, positioning the modality as a cost-effective alternative to surgery. Doppler advancements such as vector-flow mapping add hemodynamic detail to vascular studies, and AI de-noise algorithms elevate image clarity at lower transmit powers, further differentiating platforms within the Canada ultrasound devices market.
Complete Report Scope:
- By Application
- Anesthesiology
- Cardiology
- Gynecology/Obstetrics
- Radiology
- Other Applications
- By Technology
- 2D Ultrasound Imaging
- 3D and 4D Ultrasound Imaging
- Doppler Imaging
- High-Intensity Focused Ultrasound (HIFU)
- Other Technologies
- By Portability
- Stationary Systems
- Portable Laptop-Based Systems
- Handheld/Pocket Ultrasound Devices
- By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- Other End Users
List of Companies Covered in this Report:
- GE HealthCare Technologies Inc.
- Koninklijke Philips
- Siemens Healthineers
- Canon
- FUJIFILM
- Samsung Group
- Hologic
- Mindray Bio-Medical Electronics Co., Ltd.
- Esaote S.p.A.
- Clarius Mobile Health Corp.
- Butterfly Network, Inc.
- Hitachi
- Analogic
- Terason Division - Teratech Corporation
- Supersonic Imagine
- Wisonic Medical Technology Co., Ltd.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- GE HealthCare Technologies Inc.
- Koninklijke Philips N.V.
- Siemens Healthineers AG
- Canon Medical Systems Corporation
- FUJIFILM Holdings Corporation
- Samsung Medison Co., Ltd.
- Hologic, Inc.
- Mindray Bio-Medical Electronics Co., Ltd.
- Esaote S.p.A.
- Clarius Mobile Health Corp.
- Butterfly Network, Inc.
- Hitachi, Ltd.
- Analogic Corporation
- Terason Division – Teratech Corporation
- Supersonic Imagine
- Wisonic Medical Technology Co., Ltd.

